HomeCariprazineCariprazine + Cyp3a Inducers

Does Cariprazine Interact with Cyp3a Inducers?

Cariprazine and Cyp3a Inducers have a moderate drug interaction according to U.S. FDA drug labeling data. Concomitant use with CYP3A4 inducers is not recommended as the net effect on cariprazine exposure is unclear and effects have not been evaluated. The mechanism involves cyp3a4 responsible for formation and elimination of cariprazine active metabolites. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Cariprazine Class
Atypical Antipsychotic
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Cariprazine and Cyp3a Inducers occurs because cyp3a4 responsible for formation and elimination of cariprazine active metabolites. Clinically, this means concomitant use with cyp3a4 inducers is not recommended as the net effect on cariprazine exposure is unclear and effects have not been evaluated. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.

What To Tell Your Doctor or Pharmacist

If you are taking Cariprazine and your doctor is considering prescribing Cyp3a Inducers (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Cariprazine(Vraylar)+💊 Cyp3a Inducers

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Atypical Antipsychotic
Drug B class
Source
NLP:cariprazine

What this means in plain English

Concomitant use with CYP3A4 inducers is not recommended as the net effect on cariprazine exposure is unclear and effects have not been evaluated.

About Cariprazine and Cyp3a Inducers

Cariprazine is an Atypical Antipsychotic. Cariprazine is also sold under the brand name Vraylar. Cariprazine is taken by mouth. Cariprazine additionally carries an FDA boxed warning, the FDA's strongest safety alert.

What the FDA label says

"CYP3A4 responsible for formation and elimination of cariprazine active metabolites"

📖 Source: NLP:cariprazine

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Cariprazine and Cyp3a Inducers against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.